However, in the case of LY294002 treatment, more significant suppression in osteogenic differentiation was observed in cells with rAd-HGF infection (p < 0.05), which is as an even more obvious situation when compared with DMSO-treated hBMSCs infected with rAd-HGF (p < 0.001). Here, HGF is linked to infection.